Health care evidence with managed care consequences.
Managed Care Cast follows American Journal of Managed Care editors through measured conversations with clinicians, researchers, policy voices, and health care professionals. Its strongest episodes translate technical findings into practical stakes around cancer care, medication access, equity, Medicare spending, and managed care decision-making.
PRESS PLAY
Managed Care Cast is a measured editorial interview series from the American Journal of Managed Care. Its subject is health care as it is actually delivered: through clinicians, plans, employers, public programs, research evidence, patient behavior, and uneven access. The show works best when it starts with a narrow question and follows it until the larger system comes into focus. A conversation about breast cancer prevention becomes a discussion of diet, alcohol, exercise, BMI, GLP drugs, underrepresented populations, and the difference between reactive care and prevention. A myeloma episode uses frailty and aging to ask how innovation reaches older adults, including therapies such as CAR-T and bispecific antibodies. A cardiology spending episode looks at industry payments, Medicare beneficiary costs, and what public data can show without overstating causality. The pacing is steady. The questions are direct, but they leave room for qualification. Recent episodes also cover AI in radiology and malpractice risk, pediatric vaccination after CDC schedule changes, health inequities as an employer cost, text message nudges for heart failure prescription fills, and grocery card supplemental benefits for dual-eligible beneficiaries. That range gives the show a distinctive managed care lens. It does not treat science, policy, and operations as separate worlds. Instead, it keeps asking how evidence changes workflows, access, utilization, trust, and patient engagement. The conversations can get technical, especially around study design, risk assessment, medication management, and spending implications. They remain oriented toward consequences. Listeners hear researchers describe methods, clinicians weigh tradeoffs, and policy voices connect interventions to access. The show is especially useful for people who need to understand why a finding matters beyond the abstract. It is careful without being inert. Its value is in the translation from evidence to action.
Made for: Built for health care professionals, policy watchers, payer and provider leaders, researchers, and clinically curious listeners who want more than surface-level medical news. It especially suits people tracking how evidence affects access, coverage, quality, utilization, and patient outcomes.
What sets it apart: The show’s strength is its editorial managed care frame: clinical findings are consistently tied back to incentives, workflows, equity, and real-world implementation. It gives studies and policy changes enough context to matter without turning them into advocacy slogans.
Podcast by Managed Care Cast
Based on 4 episodes we listened to · September 2026
Managed Care Cast makes clinical tradeoffs clearer by connecting treatment evidence with comorbidities, access, quality of life, and patient preference.
Managed Care Cast turns clinical decision-making into careful, question-led conversations with specialists. Produced by the American Journal of Managed Care, it moves from blood cancer treatment choices to seasonal affective disorder and lifestyle-related breast cancer risk,…
Treatment choices arrive with cost and comorbidities attached, right where your easy answers should wobble.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A careful look at how myeloma care is changing for older adults.
The episode focuses on multiple myeloma through aging and equity, and Dr. McHale gives Maggie Shore a clear account of how older adults, once left behind by intensive therapies, are now benefiting from safer, more targeted, and more effective options.
A clinician-led look at how seasonal shifts can affect mood, sleep, and appetite.
The episode gives seasonal affective disorder a clear, practical framing. Dr. Craig Sawchuck explains why winter sadness is more than a vague slump, then draws a clean line between SAD and recurrent mood disorders such as major depressive disorder or bipolar disorder.
A careful look at lifestyle, evidence gaps, and underrepresented populations in breast cancer prevention research.
Managed Care Cast uses a practical question, how lifestyle fits into breast cancer risk reduction, to open a more careful discussion about evidence gaps, representation, and newer weight-changing agents. Ella Holman speaks with Dr.
A focused, technical review of how risk, comorbidities, cost, and preference shape BTK inhibitor decisions.
Treatment-naive CLL and MCL seldom fall into a neat treatment pathway, and this Managed Care Cast episode grounds that reality in decisions around BTK inhibitors.
Measured MS science, translated for care.
Clinical research, translated for practice.
Serious conversations about better health care.
This episode discusses the implications of the US potentially withdrawing from the World Health Organization and the CDC's halted communications with the WHO, focusing on the intersection of politics and science in public health.
Ella Holman interviews Dr.
This episode features a panel discussion on BTK inhibitors for treatment-naive chronic lymphocytic leukemia and mantle cell lymphoma.
Managed Carecast marks the 45th anniversary of the CDC's first AIDS report by interviewing Perry Halkitis, dean of the Rutgers School of Public Health, about how political decisions shape public health.
Dr.
Managed CareCast host Ralph Riello and Yale cardiologist Nihar Desai examine why UACR testing for early chronic kidney disease often fails to lead to treatment.
This episode features an interview with Dr.
Managed Carecast opens on a practical question: how multiple myeloma treatment is changing for older adults.
This episode discusses research showing that industry payments to cardiologists are associated with increased Medicare spending, with authors Michael Ellenbogen and Yubin Park explaining their study's methodology, findings, and policy implications.
This episode discusses a study on how AI-assisted double-reading in radiology affects malpractice risk and jury perceptions, featuring insights from medical and legal experts.
This episode discusses the implications of recent CDC changes to the childhood immunization schedule from a managed care pharmacy perspective, featuring an interview with Susan Cantrell, CEO of the Academy of Managed Care Pharmacy.
This episode explores how health inequities cost the U.S.
This episode discusses transparency in healthcare coverage, exposing issues with ghost rates and holding national payers accountable through analysis of TIC files.
Managed Care Cast turns to seasonal affective disorder.
This episode features an interview with Dr.
This episode discusses disparities in multiple myeloma outcomes for African-American and Latino-American patients and explores the International Myeloma Foundation's M-POWER initiative to improve access to treatments and clinical trial participation.